Multiple congenital anomalies/dysmorphic syndrome without intellectual disability
MONDO:0015161Also known as: MCA without intellectual disability, multiple congenital anomalies without intellectual disability with or without dysmorphism
163 clinical trials for this condition and its sub-types, 0 tagged with Multiple congenital anomalies/dysmorphic syndrome without intellectual disability itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Multiple congenital anomalies/dysmorphic syndrome without intellectual disability
-
Fanconi anemia 29 trials · 42 incl. sub-types
22 sub-types
- Fanconi anemia complementation group D1 6 trials
- Fanconi anemia complementation group A 4 trials
- Fanconi anemia complementation group E 4 trials
- Fanconi anemia complementation group N 2 trials
- Fanconi anemia, complementation group S 2 trials
- Fanconi anemia complementation group B 0 trials
- Fanconi anemia complementation group C 0 trials
- Fanconi anemia complementation group D2 0 trials
- Fanconi anemia complementation group F 0 trials
- Fanconi anemia complementation group G 0 trials
- Fanconi anemia complementation group I 0 trials
- Fanconi anemia complementation group J 0 trials
- Fanconi anemia complementation group L 0 trials
- Fanconi anemia complementation group O 0 trials
- Fanconi anemia complementation group P 0 trials
- Fanconi anemia complementation group Q 0 trials
- Fanconi anemia complementation group R 0 trials
- Fanconi anemia complementation group T 0 trials
- Fanconi anemia complementation group U 0 trials
- Fanconi anemia complementation group V 0 trials
- Fanconi anemia, complementation group W 0 trials
- Fanconi anemia, complementation group 10 0 trials
-
CHILD syndrome 37 trials
-
Autosomal dominant prognathism 26 trials
-
Alagille syndrome 15 trials
3 sub-types
-
Van der Woude syndrome 8 trials
2 sub-types
- Van der Woude syndrome 1 0 trials
- Van der Woude syndrome 2 0 trials
-
Binder syndrome 7 trials
-
Matthew-Wood syndrome 5 trials
-
Pelvis syndrome 5 trials
-
Oculoauriculovertebral spectrum with radial defects 0 trials · 5 incl. sub-types
1 sub-type
- Craniofacial microsomia 5 trials Sub-types →
-
3 sub-types
- LEOPARD syndrome 1 0 trials
- LEOPARD syndrome 2 0 trials
- LEOPARD syndrome 3 0 trials
-
Axenfeld-Rieger syndrome 1 trial
3 sub-types
- Axenfeld-Rieger syndrome type 3 1 trial
- Axenfeld-Rieger syndrome type 1 0 trials
- Axenfeld-Rieger syndrome type 2 0 trials
-
BNAR syndrome 1 trial
-
Freeman-Sheldon syndrome 1 trial
1 sub-type
-
Nijmegen breakage syndrome 1 trial
-
Waardenburg syndrome 1 trial
5 sub-types
- Waardenburg syndrome type 1 1 trial
- Waardenburg syndrome type 2 1 trial Sub-types →
- Waardenburg syndrome type 3 0 trials
- Waardenburg syndrome, IIa 2F 0 trials
- Waardenburg-Shah syndrome 0 trials Sub-types →
-
Cherubism 1 trial
1 sub-type
-
Postaxial acrofacial dysostosis 1 trial
-
3-M syndrome 0 trials
3 sub-types
- 3M syndrome 1 0 trials
- 3M syndrome 2 0 trials
- 3M syndrome 3 0 trials
-
49,XYYYY syndrome 0 trials
-
8q22.1 microdeletion syndrome 0 trials
-
Aase-Smith syndrome 0 trials
-
Abruzzo-Erickson syndrome 0 trials
-
Ackerman syndrome 0 trials
-
Ascher syndrome 0 trials
-
Barber-Say syndrome 0 trials
-
Beemer-Ertbruggen syndrome 0 trials
-
Bencze syndrome 0 trials
-
Braddock syndrome 0 trials
-
CODAS syndrome 0 trials
-
Charlie M syndrome 0 trials
-
Cole-Carpenter syndrome 0 trials
2 sub-types
- Cole-Carpenter syndrome 1 0 trials
- Cole-Carpenter syndrome 2 0 trials
-
Cooper-Jabs syndrome 0 trials
-
Czeizel-Losonci syndrome 0 trials
-
Dahlberg-Borer-Newcomer syndrome 0 trials
-
Donohue syndrome 0 trials
-
Fontaine progeroid syndrome 0 trials
-
Fraser syndrome 0 trials
3 sub-types
- Fraser syndrome 1 0 trials
- Fraser syndrome 2 0 trials
- Fraser syndrome 3 0 trials
-
Frias syndrome 0 trials
-
Gordon syndrome 0 trials
-
Holt-Oram syndrome 0 trials
1 sub-type
- Heart-hand syndrome type 3 0 trials
-
Holzgreve-Wagner-Rehder syndrome 0 trials
-
Juberg-Hayward syndrome 0 trials
-
Keipert syndrome 0 trials
-
LADD syndrome 0 trials
3 sub-types
- LADD syndrome 1 0 trials
- Lacrimoauriculodentodigital syndrome 2 0 trials
- Lacrimoauriculodentodigital syndrome 3 0 trials
-
Marshall syndrome 0 trials
-
McKusick-Kaufman syndrome 0 trials
-
Nager acrofacial dysostosis 0 trials
-
PAGOD syndrome 0 trials
-
PARC syndrome 0 trials
-
PHAVER syndrome 0 trials
-
Richieri Costa-Pereira syndrome 0 trials
-
Richieri Costa-da Silva syndrome 0 trials
-
SHORT syndrome 0 trials
-
Schilbach-Rott syndrome 0 trials
-
Thomas syndrome 0 trials
-
Townes-Brocks syndrome 0 trials
2 sub-types
- Townes-Brocks syndrome 1 0 trials
- Townes-Brocks syndrome 2 0 trials
-
Treacher-Collins syndrome 0 trials
4 sub-types
- Treacher Collins syndrome 1 0 trials
- Treacher Collins syndrome 2 0 trials
- Treacher Collins syndrome 3 0 trials
- Treacher Collins syndrome 4 0 trials
-
Verloove Vanhorick-Brubakk syndrome 0 trials
-
Vici syndrome 0 trials
-
Warsaw breakage syndrome 0 trials
-
Weill-Marchesani syndrome 0 trials
4 sub-types
- Weill-Marchesani 4 syndrome, recessive 0 trials
- Weill-Marchesani syndrome 1 0 trials
- Weill-Marchesani syndrome 2, dominant 0 trials
- Weill-Marchesani syndrome 3 0 trials
-
Acro-renal-mandibular syndrome 0 trials
-
Acrocraniofacial dysostosis 0 trials
-
Acrofacial dysostosis, Weyers type 0 trials
-
Acrofrontofacionasal dysostosis 2 0 trials
-
Acrorenal syndrome 0 trials
1 sub-type
-
Anonychia-microcephaly syndrome 0 trials
-
Anophthalmia plus syndrome 0 trials
-
1 sub-type
-
Blepharocheilodontic syndrome 0 trials
3 sub-types
- Martinez Monasterio Pinheiro syndrome 0 trials
- Blepharocheilodontic syndrome 1 0 trials
- Blepharocheilodontic syndrome 2 0 trials
-
Branchio-oto-renal syndrome 0 trials
2 sub-types
- Branchiootorenal syndrome 1 0 trials
- Branchiootorenal syndrome 2 0 trials
-
Branchiooculofacial syndrome 0 trials
-
Branchiootic syndrome 0 trials
3 sub-types
- Branchiootic syndrome 1 0 trials
- Branchiootic syndrome 2 0 trials
- Branchiootic syndrome 3 0 trials
-
Cleft lip-retinopathy syndrome 0 trials
-
3 sub-types
-
Craniofacial-deafness-hand syndrome 0 trials
-
Craniolenticulosutural dysplasia 0 trials
-
Deafness-craniofacial syndrome 0 trials
-
Digitotalar dysmorphism 0 trials
3 sub-types
- Arthrogryposis, distal, type 1A 0 trials
- Arthrogryposis, distal, type 1B 0 trials
- Digitotalar dysmorphism; ulnar drift, hereditary 0 trials
-
Even-plus syndrome 0 trials
-
Femoral-facial syndrome 0 trials
-
Fetal akinesia deformation sequence 0 trials
5 sub-types
- Fetal akinesia deformation sequence 1 0 trials
- Fetal akinesia deformation sequence 2 0 trials
- Fetal akinesia deformation sequence 3 0 trials
- Fetal akinesia deformation sequence 4 0 trials
- Fetal akinesia syndrome, X-linked 0 trials
-
Frontofacionasal dysplasia 0 trials
-
Genito-palato-cardiac syndrome 0 trials
-
Grange syndrome 0 trials
-
Hand-foot-genital syndrome 0 trials
-
Heart-hand syndrome type 2 0 trials
-
Mandibuloacral dysplasia 0 trials
2 sub-types
-
Median nodule of the upper lip 0 trials
-
Otoonychoperoneal syndrome 0 trials
-
Pentalogy of Cantrell 0 trials
-
Rapadilino syndrome 0 trials
-
Renal-genital-middle ear anomalies 0 trials
-
Scalp-ear-nipple syndrome 0 trials
-
2 sub-types
- Tetraamelia syndrome 1 0 trials
- Tetraamelia syndrome 2 0 trials
-
Thymic-renal-anal-lung dysplasia 0 trials
-
Van den Ende-Gupta syndrome 0 trials
-
Velo-facial-skeletal syndrome 0 trials
-
Von Voss-Cherstvoy syndrome 0 trials
-
White forelock with malformations 0 trials
Most studied deeper sub-types
-
Can a daily pill boost blood counts in fanconi anemia?
Disease control OngoingFanconi anemia is a genetic condition that can damage bone marrow and lead to low blood cell counts, causing anemia, bleeding, or infections. Researchers are testing whether a daily pill called eltrombopag can improve blood counts in people with this condition. The trial enrolls …
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a Two-Drug chemo combo shrink BRCA breast tumors before surgery?
Disease control OngoingResearchers test whether giving mitomycin plus carboplatin before surgery helps people with BRCA1 or BRCA2 mutations and locally advanced triple-negative breast cancer. The trial compares this combination, followed by paclitaxel, against standard chemotherapy. About 30 adults wit…
Sponsor: N.N. Petrov National Medical Research Center of Oncology • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Clear aligner aims to guide jaw growth and fix underbite without metal braces
Disease control By invitation onlyThis trial tests a custom clear aligner designed to correct skeletal Class III malocclusion (underbite) in children aged 8-11 who are still growing. The aligner uses small bite blocks with angled surfaces to gently guide the lower jaw forward during everyday use. Researchers will…
Sponsor: Mansoura University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New transplant method aims to reduce complications in bone marrow failure patients
Disease control OngoingThis study tests a stem cell transplant method for people with acquired or inherited bone marrow failure. Donor stem cells are specially processed to remove certain immune cells, which may lower the risk of graft rejection and graft-versus-host disease. The goal is to see if this…
Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo aims to make bone marrow transplants safer for kids
Disease control OngoingThis pilot study tests a fludarabine-based drug regimen to prepare children with bone marrow failure syndromes for a bone marrow transplant from a matched sibling donor. The goal is to help the donor cells successfully take root while reducing serious side effects. The study incl…
Early phase 1 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could rubber bands replace jaw surgery for underbites?
Disease control OngoingThis study looks at whether adding rubber bands (elastics) to standard clear plastic retainers helps keep an underbite correction stable after orthodontic treatment. Researchers want to see if this simple addition can reduce the need for future jaw surgery. The trial involves 42 …
Sponsor: Sydney Local Health District • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Gene therapy for rare blood disease shows promise in Long-Term Follow-Up
Disease control By invitation onlyThis study follows 14 people with Fanconi Anemia who previously received RP-L102 gene therapy. Researchers will monitor their health for years to see if the treatment safely improves blood counts and reduces the need for a bone marrow transplant. The goal is to understand long-te…
Sponsor: Rocket Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Gene therapy for rare blood disease passes 15-Year safety watch
Disease control OngoingThis study follows 9 people with Fanconi Anemia who already received a gene therapy that adds a working FANCA gene to their blood stem cells. Researchers will check their health and blood counts for 15 years to see if the treatment remains safe and keeps working. No new treatment…
Sponsor: Rocket Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Which airway method saves more kids? major trial aims to find out
Disease control PausedThis study tests three ways emergency responders help children breathe: a bag-mask, a throat tube, or a breathing tube. It includes 3,000 children under 18 with cardiac arrest, severe injury, or breathing failure. The goal is to see which method leads to more days alive and out o…
Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug combo may shield kids from transplant complications
Disease control OngoingThis study tests whether adding the drug abatacept to standard care can prevent graft-versus-host disease (GVHD) in children receiving stem cell transplants from unrelated donors. GVHD occurs when donor cells attack the patient's body, causing serious illness. The trial will enro…
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New digital brace aims to fix underbite in kids without surgery
Disease control By invitation onlyThis early study tests a custom-made digital dental device called the Digital Bonded Reverse Twin Block in 21 children aged 8-11 with a mild underbite. The device is designed to gently shift the jaw and teeth into better alignment. Researchers will measure changes in jaw position…
Phase 1 • Sponsor: Mansoura University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Targeted drug olaparib tested in breast cancer patients with DNA repair flaws
Disease control OngoingThis phase 2 study tests the drug olaparib in 114 people with metastatic breast cancer whose tumors have mutations in certain DNA repair genes (like BRCA1, BRCA2, ATM, PALB2, and others). Olaparib is a PARP inhibitor that may kill cancer cells by blocking their ability to fix dam…
Phase 2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Experimental gene therapy aims to stop bone marrow failure in kids with rare disease
Disease control OngoingThis phase 2 trial tests a gene therapy called RP-L102 for children with Fanconi anemia subtype A, a rare genetic disorder that leads to bone marrow failure. Doctors take the child's own blood stem cells, fix the faulty gene in a lab, and infuse the corrected cells back. The goal…
Phase 2 • Sponsor: Rocket Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Double antibody attack: new hope for tough pancreatic cancer?
Disease control OngoingThis phase 2 trial tests whether adding a new antibody called HLX22 to standard treatment (trastuzumab plus chemotherapy) can shrink tumors and improve survival in people with HER2-positive pancreatic cancer that has spread. The study enrolls 45 adults who have not had prior trea…
Phase 2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Glow-in-the-Dark mouth scans could catch cancer early
Diagnosis OngoingThis study tests whether special lights and cameras can help find early signs of mouth cancer in people at high risk. About 338 participants with precancerous spots or conditions like Fanconi anemia will have their mouths examined with fluorescence imaging, which makes abnormal c…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Can Eco-Friendly education extend breastfeeding?
Prevention OngoingThis trial tests whether an educational program on sustainable diet and breastfeeding, given before delivery, can increase the number of mothers who exclusively breastfeed for up to six months. The study includes 429 pregnant women and also measures the environmental impact of di…
Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
New tooth sealant could protect Kids' molars even when wet
Prevention OngoingThis study tests a special tooth sealant that works even on wet teeth. Researchers will apply the sealant to 500 molars in 250 children aged 7-11, comparing how well it holds up when the tooth is dried for 3 seconds versus 15 seconds. The goal is to see if the sealant prevents ca…
Sponsor: Afyonkarahisar Health Sciences University • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
New hope for kids with rare liver disease: long-term drug study launched
Symptom relief OngoingThis study looks at the long-term safety and effectiveness of odevixibat in 70 people with Alagille syndrome, a rare genetic condition that affects the liver and other organs. The drug aims to reduce severe itching and improve bile flow. Participants who completed a prior 24-week…
Phase 3 • Sponsor: Albireo, an Ipsen Company • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Experimental drug offered to cancer patients with severe wasting
Symptom relief Expanded access (ended)This expanded access program gives seriously ill adults with advanced pancreatic cancer and cachexia (severe weight loss and muscle wasting) access to the experimental drug mifomelatide. Patients receive a daily injection for up to 13 weeks. The goal is to provide a potential tre…
Sponsor: Endevica Bio • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Breathing carbon dioxide to uncover hidden stroke risks in kids
Knowledge-focused OngoingThis study looks at how blood flow and metabolism affect brain development in children with sickle cell anemia. Researchers will use MRI scans and a special mask to have participants breathe carbon dioxide, which helps measure how well brain blood vessels expand. The goal is to u…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Mailed DNA kits could boost cancer prevention in families
Knowledge-focused OngoingThis study tests whether offering online educational videos and mailed saliva genetic testing kits helps more first-degree relatives of people with BRCA mutations get tested, compared to standard care with a family letter. About 820 participants will be enrolled across several me…
Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Major study on rare childhood liver diseases halted
Knowledge-focused PausedThis study followed children and young adults with genetic liver diseases that cause bile buildup. The goal was to track how these diseases progress over time, including the need for liver transplants or other complications. No treatments were tested; the aim was simply to learn …
Sponsor: Arbor Research Collaborative for Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
450 babies help scientists unlock secrets of healthy eating
Knowledge-focused OngoingThis study follows 450 infants and their families from birth to age 12 to learn how a child's biology and home environment work together to shape eating habits and growth. Researchers collect samples, measurements, and surveys at regular visits. The goal is to understand what inf…
Sponsor: University of Illinois at Urbana-Champaign • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Massive PT study mines 4 million records to find what works best
Knowledge-focused OngoingThis study looks back at the medical records of about 4 million people who had physical or occupational therapy for muscle and joint problems. Researchers want to see if different ways of giving therapy lead to different results. No new treatments are tested—the goal is to learn …
Sponsor: ATI Holdings, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
HT-1 drug study in china withdrawn before starting
Knowledge-focused CancelledThis study was designed to observe how patients with hereditary tyrosinemia type 1 (HT-1) in China respond to nitisinone treatment in everyday medical practice. It planned to track serious health events like liver problems or death. However, the study was withdrawn before enrolli…
Sponsor: Swedish Orphan Biovitrum • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Tooth tilt may predict jaw widening success
Knowledge-focused By invitation onlyThis study looks at 200 people with a narrow upper jaw who are getting a palate expander. Researchers want to see if the angle of the premolars on X-rays can predict how much the jaw will widen. The goal is to better understand the treatment process, not to test a new therapy.
Sponsor: University of Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New algorithm aims to catch ovarian damage early in young cancer survivors
Knowledge-focused CancelledThis study was designed to see if a new monitoring algorithm could detect early signs of ovarian damage in women and girls who had cancer treatment. Researchers planned to compare a group using the new algorithm with a group that received standard care. However, the study was wit…
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:42 UTC